» Articles » PMID: 19432455

Biophysical Interactions with Model Lipid Membranes: Applications in Drug Discovery and Drug Delivery

Overview
Journal Mol Pharm
Specialty Pharmacology
Date 2009 May 13
PMID 19432455
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

The transport of drugs or drug delivery systems across the cell membrane is a complex biological process, often difficult to understand because of its dynamic nature. In this regard, model lipid membranes, which mimic many aspects of cell-membrane lipids, have been very useful in helping investigators to discern the roles of lipids in cellular interactions. One can use drug-lipid interactions to predict pharmacokinetic properties of drugs, such as their transport, biodistribution, accumulation, and hence efficacy. These interactions can also be used to study the mechanisms of transport, based on the structure and hydrophilicity/hydrophobicity of drug molecules. In recent years, model lipid membranes have also been explored to understand their mechanisms of interactions with peptides, polymers, and nanocarriers. These interaction studies can be used to design and develop efficient drug delivery systems. Changes in the lipid composition of cells and tissue in certain disease conditions may alter biophysical interactions, which could be explored to develop target-specific drugs and drug delivery systems. In this review, we discuss different model membranes, drug-lipid interactions and their significance, studies of model membrane interactions with nanocarriers, and how biophysical interaction studies with lipid model membranes could play an important role in drug discovery and drug delivery.

Citing Articles

Investigating drug-liposome interactions using liposomal electrokinetic chromatography.

Simonova A, Balouch M, Stepanek F, Krizek T Anal Bioanal Chem. 2025; .

PMID: 39939418 DOI: 10.1007/s00216-025-05783-6.


The Langmuir Monolayer as a Model Membrane System for Studying the Interactions of Poly(Butyl Cyanoacrylate) Nanoparticles with Phospholipids at the Air/Water Interface.

Yordanov G, Minkov I, Balashev K Membranes (Basel). 2024; 14(12).

PMID: 39728704 PMC: 11678612. DOI: 10.3390/membranes14120254.


Binding of -[Ru(phen)(3,4Apy)] to Model Lipid Membranes: Implications for New Tools in the Development of Antiamyloid Drugs.

da Cruz Garcia M, Paixao R, Pazin W, Oliveira Jr O, Cremer P, Carlos R Langmuir. 2024; 40(52):27345-27355.

PMID: 39682054 PMC: 11697347. DOI: 10.1021/acs.langmuir.4c03552.


SMARTINI3 parametrization of multi-scale membrane models via unsupervised learning methods.

Soleimani A, Risselada H Sci Rep. 2024; 14(1):25714.

PMID: 39468134 PMC: 11519956. DOI: 10.1038/s41598-024-75490-2.


Advancements in Engineering Planar Model Cell Membranes: Current Techniques, Applications, and Future Perspectives.

Coronado S, Herrera J, Pino M, Martin S, Ballesteros-Rueda L, Cea P Nanomaterials (Basel). 2024; 14(18).

PMID: 39330645 PMC: 11434481. DOI: 10.3390/nano14181489.


References
1.
Preetha A, Huilgol N, Banerjee R . Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes. J Membr Biol. 2007; 219(1-3):83-91. DOI: 10.1007/s00232-007-9064-6. View

2.
Deshayes S, Morris M, Divita G, Heitz F . Interactions of amphipathic CPPs with model membranes. Biochim Biophys Acta. 2005; 1758(3):328-35. DOI: 10.1016/j.bbamem.2005.10.004. View

3.
Kabanov A, Batrakova E, Alakhov V . Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev. 2002; 54(5):759-79. DOI: 10.1016/s0169-409x(02)00047-9. View

4.
Escriba P . Membrane-lipid therapy: a new approach in molecular medicine. Trends Mol Med. 2005; 12(1):34-43. DOI: 10.1016/j.molmed.2005.11.004. View

5.
Liu J, Conboy J . Structure of a gel phase lipid bilayer prepared by the Langmuir-Blodgett/Langmuir-Schaefer method characterized by sum-frequency vibrational spectroscopy. Langmuir. 2005; 21(20):9091-7. DOI: 10.1021/la051500e. View